MariMed Inc.
MRMD
$0.0725
$0.00141.97%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 157.99M | 157.96M | 157.86M | 156.07M | 152.15M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 157.99M | 157.96M | 157.86M | 156.07M | 152.15M |
| Cost of Revenue | 96.45M | 95.10M | 90.39M | 88.53M | 85.15M |
| Gross Profit | 61.53M | 62.87M | 67.48M | 67.54M | 67.00M |
| SG&A Expenses | 60.52M | 59.01M | 59.90M | 58.34M | 55.14M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 156.97M | 154.10M | 150.28M | 146.88M | 140.29M |
| Operating Income | 1.02M | 3.86M | 7.58M | 9.19M | 11.86M |
| Income Before Tax | -6.96M | -3.97M | -10.35M | -9.81M | -8.03M |
| Income Tax Expenses | 9.30M | 8.16M | 3.72M | 7.53M | 8.61M |
| Earnings from Continuing Operations | -16.26 | -12.13 | -14.07 | -17.34 | -16.64 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -63.00K | -37.00K | -64.00K | -38.00K | -49.00K |
| Net Income | -16.32M | -12.16M | -14.13M | -17.38M | -16.68M |
| EBIT | 1.02M | 3.86M | 7.58M | 9.19M | 11.86M |
| EBITDA | 12.32M | 14.72M | 17.95M | 19.31M | 21.20M |
| EPS Basic | -0.04 | -0.03 | -0.04 | -0.05 | -0.04 |
| Normalized Basic EPS | -0.01 | 0.00 | 0.00 | 0.00 | 0.01 |
| EPS Diluted | -0.04 | -0.03 | -0.04 | -0.05 | -0.04 |
| Normalized Diluted EPS | -0.01 | 0.00 | 0.00 | 0.00 | 0.01 |
| Average Basic Shares Outstanding | 1.52B | 1.52B | 1.51B | 1.50B | 1.49B |
| Average Diluted Shares Outstanding | 1.52B | 1.52B | 1.51B | 1.50B | 1.49B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -0.74% | -1.36% | -1.17% | -1.00% | -1.04% |